Vacunas SARS-CoV-2 / Vaccines SARS-CoV-2
Rev. Hosp. Clin. Univ. Chile
;
32(2): 168-176, 2021.
Artigo
em Espanhol
| LILACS
| ID: biblio-1342508
ABSTRACT
Vaccines are biological products that stimulate the immune system to generate specific responses and immune memory. Faced with the magnitude of the problem caused by the Covid-19 pandemic, there is an urgent need to find an effective and safe preventive intervention. The race to find the ideal vaccine against this new coronavirus has required optimizing research times on this topic. Currently, more than 200 SARS-CoV-2 vaccine candidates are in development, 177 in preclinical evaluation, 63 in clinical evaluation and 16 of them in phase 3 of clinical trials. In our country, 3 SARS-CoV-2 vaccines are already authorized for administration, which have demonstrated safety and efficacy in clinical trials. (AU)
Texto completo:
DisponíveL
Índice:
LILACS (Américas)
Assunto principal:
Vacinas contra COVID-19
Limite:
Feminino
/
Humanos
/
Masculino
Idioma:
Espanhol
Revista:
Rev. Hosp. Clin. Univ. Chile
Assunto da revista:
Medicina
Ano de publicação:
2021
Tipo de documento:
Artigo
País de afiliação:
Chile
Instituição/País de afiliação:
Hospital Clínico de la Universidad de Chile/CL
Similares
MEDLINE
...
LILACS
LIS